FDA Approves Zituvimet XR (sitagliptin and metformin hydrochloride) Extended-Release Tablets for Adults with Type 2 Diabetes

FDA approves Zituvimet XR, a sitagliptin and metformin hydrochloride extended-release tablet, for adults with type 2 diabetes, manufactured by Zydus Lifesciences Limited.


Related News

FDA Approves Zituvimet XR (sitagliptin and metformin hydrochloride) Extended-Release Tablets for Adults with Type 2 Diabetes

FDA approves Zituvimet XR, a sitagliptin and metformin hydrochloride extended-release tablet, for adults with type 2 diabetes, manufactured by Zydus Lifesciences Limited.

© Copyright 2024. All Rights Reserved by MedPath